Leveraging Innovation To Deliver Precision Medicines

Jubilant Therapeutics

Jubilant Therapeutics is a patient-centric biopharmaceutical company advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases.

Our Strategy

Focus on unmet medical needs

Focus on unmet medical needs resulting from specific genetic mutations, drug resistance, or compensatory mechanisms

internally discovered

Build a portfolio of internally discovered and selectively acquired programs structured into asset-based subsidiaries

Fast track

Fast track promising assets from discovery to clinical proof of concept

creative partnerships

Advance programs into pivotal studies and commercialization through creative partnerships

proven and synergistic capabilities

Leverage proven and synergistic capabilities of Jubilant Pharmova's world-class research with in-house development expertise

Events

13th – 15th Sep 2021

H.C. Wainwright 23rd Annual Global Investment Conference

Corporate Presentation
Presenter: Syed Kazmi

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.